XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand itβs campus headquarters with the construction of a new, state-of-the-art research and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.55 | -7.67085076709 | 7.17 | 7.43 | 6.36 | 55389 | 6.69730308 | CS |
4 | -0.57 | -7.92767732962 | 7.19 | 8.32 | 6.36 | 56390 | 7.2867668 | CS |
12 | -0.15 | -2.21565731167 | 6.77 | 8.32 | 5.62 | 47806 | 7.11127321 | CS |
26 | -1.92 | -22.4824355972 | 8.54 | 9.05 | 4.24 | 72313 | 6.47820772 | CS |
52 | 2.98 | 81.8681318681 | 3.64 | 9.96 | 3.51 | 62628 | 6.76465314 | CS |
156 | -6.18 | -48.28125 | 12.8 | 13.12 | 3 | 60794 | 6.40814089 | CS |
260 | -7.44 | -52.9160739687 | 14.06 | 33.2 | 3 | 129296 | 14.54761506 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.